Semler Scientific, Inc. (SMLR)

Market Cap	310.75M -23.9%
Revenue (ttm)	36.96M -37.3%
Net Income	48.34M +203.7%
EPS	4.07 +99.6%
Shares Out	15.29M
PE Ratio	5.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,624,179
Open	21.37
Previous Close	n/a
Day's Range	20.27 - 21.39
52-Week Range	14.89 - 66.50
Beta	1.32
Analysts	Strong Buy
Price Target	78.40 (+285.64%)
Earnings Date	Feb 17, 2026

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, ind...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 79
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2024, Semler Scientific's revenue was $56.29 million, a decrease of -17.44% compared to the previous year's $68.18 million. Earnings were $40.90 million, an increase of 98.70%.

Analyst Summary

According to 5 analysts, the average rating for SMLR stock is "Strong Buy." The 12-month stock price target is $78.4, which is an increase of 285.64% from the latest price.

Price Target

$78.4

(285.64% upside)

Analyst Consensus: Strong Buy